German Software Stock News

Context for Deutsche Telekom’s Recent Share Performance Deutsche Telekom (XTRA:DTE) has drawn investor attention after a strong month, with the share price up about 23%, and a gain of roughly 21% over the past 3 months, prompting closer scrutiny of its fundamentals. See our latest analysis for Deutsche Telekom. That recent 23.1% 1 month share price return, on top of a 19.8% year to date share price return at around €33.32, sits alongside a 3 year total shareholder return of 72.5% and 5 year...

Volkswagen (XTRA:VOW3) has appointed Andreas Mindt as the new Group Head of Design. Mindt succeeds Michael Mauer as part of a generational transition in the company’s top design leadership. The move signals a refreshed approach to design at group level across the Volkswagen brands. For an automaker of Volkswagen’s scale, design is not just about looks; it shapes brand identity, pricing power, and how models stand out in crowded segments. As XTRA:VOW3 continues to compete across combustion,...

Fresenius Medical Care (XTRA:FME) closed out FY 2025 with Q4 revenue of €5.1b and basic EPS of €1.14, as full year trailing twelve month figures showed total revenue of €19.6b and EPS of €3.36. Over the past year, the company has seen quarterly revenue move between about €4.8b and €5.1b, while basic EPS has ranged from €0.52 in Q1 2025 to €1.14 in Q4 2025. This has occurred alongside trailing twelve month net income of €978m, which sits against earlier figures such as €538m at the end of...

SUSS MicroTec SE recently concluded a new syndicated loan agreement worth €115 million with a five-year term and two optional one-year extensions, replacing its prior €56 million facility that was set to expire in October 2026. By more than doubling its syndicated loan capacity with a consortium of renowned European banks, the company has increased its financial flexibility for general corporate needs and refinancing. Next, we’ll examine how this expanded €115 million syndicated loan...

Stock context and recent performance snapshot Dr. Ing. h.c. F. Porsche (XTRA:P911) has stayed on investors’ radar after recent trading, with the share price closing at €41.55 and short term returns mixed across the past week and month. Over the past 3 months the stock shows a negative total return, and the 1 year and 3 year total return figures are also negative. This may prompt you to look more closely at how current pricing compares with the company’s earnings and balance sheet. See our...

Elmos Semiconductor (XTRA:ELG) has put shareholder returns in focus by approving a share buyback of up to €10.0 million and proposing a 50% dividend increase following its preliminary 2025 results. See our latest analysis for Elmos Semiconductor. The buyback and proposed dividend increase arrive after a strong run in the shares, with the share price at €127.6 and a 30 day share price return of 16.21%, while the 1 year total shareholder return stands at 78.42%, indicating strong positive...

Why Bayer (XTRA:BAYN) Is Drawing Investor Attention Now Bayer (XTRA:BAYN) has been on many investors’ radar after a mixed set of figures, with full year revenue of €45.9b alongside a net loss of €198m. This has prompted fresh interest in how the share price reflects this profile. See our latest analysis for Bayer. The mixed full year figures arrive after a 90 day share price return of 38.83% and a 1 year total shareholder return of 93.07%. The 7 day share price return of 6.83% and 30 day...

If you are wondering whether Siemens Healthineers is attractively priced at its current level, this article walks through what the numbers suggest and how that might matter for your portfolio. The stock last closed at €41.55, with returns of 1.5% over 7 days, a 4.0% decline over 30 days, a 5.9% decline year to date and a 21.9% decline over 1 year. These moves may catch the eye of investors weighing potential upside against recent share price pressure. Recent news flow around Siemens...

Infineon’s new bond issues and why they matter for equity investors Infineon Technologies (XTRA:IFX) has just raised fresh debt across three new euro bonds, a move that gives the semiconductor group extra flexibility around funding, refinancing, and future investment plans. The company completed fixed income offerings totaling about €2.0b on 12 February 2026, issuing unsubordinated unsecured notes with fixed coupons and staggered maturities in 2031, 2034, and 2037. See our latest analysis for...

If you are wondering whether SAP's current share price gives you good value for your money, this article will walk through what the numbers actually say rather than just the market noise. SAP recently closed at €167.86, with returns of a 0.3% decline over 7 days, a 15.2% decline over 30 days, a 16.9% decline year to date and a 38.3% decline over 1 year. The 3 year and 5 year returns sit at 61.0% and 76.3% respectively. These moves have put SAP back on many watchlists, as investors reassess...

Commerzbank stock overview after recent performance data Commerzbank (XTRA:CBK) is back in focus as investors assess its recent share performance, including a roughly flat move over the past month and a positive total return over the past 3 months. See our latest analysis for Commerzbank. While the share price has eased slightly in the last day, a 5.1% 7 day share price return and 5.7% 90 day share price return contrast with a year to date share price decline, alongside a very large 5 year...

Deutsche Lufthansa (XTRA:LHA) is back in focus after a 54.51% share price drop on 23 February 2026, as sector weakness, margin pressure and elevated leverage met rising tension around the 6 March earnings announcement. See our latest analysis for Deutsche Lufthansa. The sharp 54.51% one day share price drop stands in contrast to Deutsche Lufthansa’s 30 day share price return of 4.27% and 1 year total shareholder return of 46.39%. This suggests that recent selling pressure has interrupted what...

Investor focus around Fresenius Medical Care (XTRA:FME) is building ahead of its 24 February 2026 earnings release, as the market weighs revenue, margin and regional performance alongside the recent MOU in Korea on high-volume hemodiafiltration. See our latest analysis for Fresenius Medical Care. Recent momentum has been mixed, with a 1 month share price return of 11.20% and a year to date share price return of 3.04%, set against a 1 year total shareholder return decline of 4.60%. This...

Siemens Energy (XTRA:ENR) is back in focus after its three largest shareholders urged management to fix the loss-making wind turbine unit before any spin off, following a 2025 loss and a recent push from activist Ananym Capital. See our latest analysis for Siemens Energy. The recent push from core shareholders comes after a strong run in Siemens Energy’s share price, with a 30 day share price return of 17.28% and a 1 year total shareholder return of 198.90% highlighting strong momentum. Multi...

With no single headline event driving attention today, Siemens (XTRA:SIE) is drawing interest as investors weigh its recent share performance, current fundamentals, and how its diversified industrial and technology portfolio might fit into broader portfolios. See our latest analysis for Siemens. Siemens’ €240.85 share price comes after a recent 7 day share price return of 2.51%, while a softer 30 day share price return of 5.33% contrasts with a 12.77% 1 year total shareholder return and...

Symrise (XTRA:SY1) has launched a €400 million share repurchase program. The company aims to buy back up to 10% of its share capital by October 2026, with redeemed shares reducing registered capital. See our latest analysis for Symrise. At a share price of €75.8, Symrise has seen positive short term momentum with a 30 day share price return of 4.44% and a 90 day return of 7.76%. However, the 1 year total shareholder return of 22.03% decline shows longer term holders have faced weaker outcomes...

Actinium-225 expansion reshapes Eckert & Ziegler’s role in radiopharmaceutical supply Eckert & Ziegler (XTRA:EUZ) has moved its Actinium-225 collaboration with the Czech Academy of Sciences into large scale production, making it one of the few suppliers able to deliver clinically relevant quantities globally. See our latest analysis for Eckert & Ziegler. The Actinium-225 expansion comes as Eckert & Ziegler’s €15.19 share price has a 1 day share price return of 2.5% and a 7 day share price...

TeamViewer (XTRA:TMV) is back in focus after its fourth quarter and full year 2025 earnings, with higher sales but lower full year net profit, alongside refreshed analyst coverage and ratings. See our latest analysis for TeamViewer. The mixed earnings picture and renewed analyst coverage come against a weak share price backdrop, with a 30 day share price return showing a 16.56% decline and a 1 year total shareholder return of 61.75% decline, suggesting sentiment has cooled even as revenue has...

Why the GSPC LNG deal matters for Uniper shares Uniper (XTRA:UN0) has signed a long term LNG supply agreement with Gujarat State Petroleum Corporation in India, linking the German utility more closely to one of the world’s fastest growing energy markets. See our latest analysis for Uniper. Despite the new LNG agreement with GSPC and a recent run of positive short term share price returns, including a 16.5% 90 day share price return to €35.7, Uniper’s 1 year total shareholder return of around...

RWE’s Vanguard West turbine deal: why it matters for shareholders RWE (XTRA:RWE) has agreed a contract with Vestas to supply and commission 92 offshore wind turbines for its Vanguard West project in the UK, a key step following the project’s government backed Contracts for Difference award. The 1.4GW Vanguard West wind farm, developed with partner KKR, is planned to power around 1.5 million UK homes annually, with RWE aiming for a Final Investment Decision in summer 2026 and commissioning in...

Münchener Rückversicherungs-Gesellschaft in München (XTRA:MUV2) has attracted fresh attention after recent share price moves, with the stock showing positive returns over the past month and the past 3 months. See our latest analysis for Münchener Rückversicherungs-Gesellschaft in München. Those recent gains sit within a steadier picture, with the share price now at €542.0, a 1-month share price return of 6.78% and a 1-year total shareholder return of 8.86%. The 3-year total shareholder return...

What triggered the latest move in Knorr-Bremse stock? Knorr-Bremse (XTRA:KBX) shares reacted to the company’s full year 2025 earnings update, where management reported strong business performance under its BOOST program and issued 2026 guidance for €8.0 to €8.3 billion in revenue and an operating EBIT margin around 14%. See our latest analysis for Knorr-Bremse. Beyond the immediate reaction to the 2025 results and 2026 guidance, Knorr-Bremse’s recent move fits into a stronger trend, with a 30...

Bayer (XTRA:BAYN) has proposed a multibillion dollar nationwide class action settlement aimed at resolving current and future U.S. lawsuits tied to alleged cancer risks from Roundup. The settlement framework seeks broad claimant participation and court approval to bring more predictability to Bayer's long running glyphosate litigation exposure. At the same time, the U.S. Supreme Court is hearing a key appeal that could influence how federal law interacts with state level failure to warn...

If you are wondering whether Mercedes-Benz Group is still offering fair value at its current share price, this article will walk through what the numbers suggest and what that could mean for you as a shareholder or prospective investor. The stock last closed at €59.40, with returns of 2.5% over the past week, 3.2% over the past month, a 4.1% decline year to date, and a 5.5% return over the past year, along with a 1.6% return over three years and 50.0% over five years. Recent coverage of...